Concord Drugs

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue11.548.797.3912.6214.47
Expenses11.538.166.6312.8815.05
EBITDA0.741.401.530.560.19
EBIT0.441.021.150.17-0.20
Profit Before Tax0.020.630.77-0.26-0.57
Net Profit0.070.490.53-0.24-0.35
Financial Ratios
Operating Profit Margin6.41%15.93%20.87%4.44%1.31%
Net Profit Margin0.61%5.57%7.18%-1.90%-2.42%
Earning Per Share (Diluted)0.070.520.56-0.24-0.35
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ